The level of nonenzymatically e-lysine-bound glucose (NEBG) of tissue proteins obtained at autopsy has been determined with a specific method recently described. 5 The mean values expressed as nmol lysinebound glucose per /imol phenylalanine were 34 for tendon, 13 for aorta, 16 for coronary artery, 23.5 for femoral nerve, 10 for glomerular basement membrane, and 30 for lung parenchyma for tissues from nondiabetics and 86, 39.5, 34, 60, 29, and 57 for tissues from diabetics, respectively. NEBG was below detection limit in skeletal muscle from either nondiabetic or diabetic subjects. Tendon and aorta NEBG levels correlated well with those from other tissues (r = 0.8-0.94, except r = 0.68 for glomerular basement membrane). A fairly good correlation was also found when NEBG of aorta was compared with the mean blood sugar level determined during the last weeks of hospitalization. Finally, an arbitrary index of diabetic late complication was compared with NEBG of aorta. There appears to be a tendency of an increase of the index of complications along with an increase in tissue glucosylation. The possible role of nonenzymatic glucosylation in the long-term complication of diabetes is discussed. DIABETES 37:1123-1127, December 1982.
cosylation (NEG) in a variety of tissues from diabetic and nondiabetic patients obtained at autopsy. It should be mentioned that the method used in this study is specific for eamino-lysine-bound glucose which is only formed by chemical and not by enzymatic reaction. Our data indicate increased amounts of nonenzymatically bound glucose (NEBG) in arterial blood vessels, connective tissues, glomerular basement membranes, and peripheral nerve from diabetic individuals similar as known for serum and red cell proteins. NEBG of muscular tissue was not increased in diabetics. These findings are consistent with the contention that the glucose concentration in tissues liable to late complications is elevated depending on the level of glycemia, and that this change leads to enhanced NEG of proteins.
MATERIALS AND METHODS
Samples from various tissues of nondiabetics and longstanding maturity-onset diabetics were obtained at autopsy and were extensively rinsed with PBS buffer to remove adherent blood. Diagnosis, onset, duration, therapy, and data on diabetic late complications were taken from the case histories. Macroangiopathy and nephropathy were diagnosed at autopsy by macroscopical and microscopical examination.
Samples of tendon (ligament of digastric muscle) and peripheral nerve (femoral nerve) were analyzed without further manipulation. The samples of coronary artery (offspring of the anterior interventricular ramus) and of the thoracic aorta were stripped of adventitia before analysis.
Glomeruli were prepared from kidney cortex according to Krakower et al. 2 Glomerular basement membranes were obtained by sonification and detergent treatment as described by Meezan et al. 3 Purity was checked by phase contrast microscopy. Connective tissue from lung parenchyma consisting mainly of collagen and elastin was prepared according to John and Thomas, 4 omitting the last alkaline purification step.
ASSAY FOR NEBG
Routinely, ca. 20 mg of wet tissue was hydrolyzed in 1 ml 6 N HCI for 18 h at 95°C as described. 5 After filtration, the hy- drolysate was diluted with 2 ml water and analyzed by HPLC. For furosine analysis of tissue samples the HPLC system originally described for glycosyl-albumin 5 was modified by the addition of an anionic detergent to achieve sufficient clear separation of furosine. The eluent consisted of 1.2 mmol/L H 3 PO 4 and 0.2 mmol/L heptane sulfonic acid (Serva, Heidelberg, GFR).
Calibration was performed with a synthetic fructose lysine standard prepared as described previously 5 and treated like tissue samples. NEBG was expressed as nmol lysinebound glucose either per mg wet tissue or per jumol phenylalanine (phe) the latter determined also by HPLC.
Albumin samples containing a known amount of lysinebound glucose were used as standards to certify the validity of the HPLC system. Disintegrated tissue samples were also reduced with NaBH 4 prior to analysis to prove the specificity of the method. Hemoglobin in tissue samples was determined according to Holzer et al. 6 For statistical analysis, the Wilcoxon test was used. The diabetic and nondiabetic groups were age-and sex-matched.
RESULTS
The amount of NEBG of tendon, aorta, coronary artery, peripheral nerve, lung parenchymal connective tissue, and glomerular basement membrane is presented in Figure 1 .
Comparison of NEBG of tissues from diabetic and nondiabetic individuals shows that on the average the level in diabetics is at least two times higher than that found in nondiabetics. This difference is significant at P < 0.005 for all tissue samples. Glucosylated hemoglobin was excluded as a contaminating source of NEBG by determination of the hemoglobin content of tissue sample aliquots. It is clear from Figure 1 that, unlike those in nondiabetic subjects, the tissues from diabetics show large variations of NEBG. This probably reflects the interindividually different levels of hyperglycemia corresponding to the former achievement of metabolic control. If this is true, different tissues from the same individuals should show comparable changes in NEBG. This was confirmed for tendon and aorta as illustrated in Figure 2 . Tendon and aorta NEBG levels correlated also well with those of the other tissues with coefficients varying from 0.84 to 0.94, except a lower value (0.68) for glomerular basement membrane (Table 1) . From these results, it would appear that the NEBG level of tissues present after death reflects the free glucose concentrations which had existed in these tissues. This is further supported by the data in Figure 3 , which indicates a fairly good correlation of the amounts of NEBG of aortic tissue with the mean blood sugar level during the last weeks of hospitalization. It is worth noting that a similar correlation exists for diabetic patients between mean blood sugar levels and NEBG of hemoglobin (HbA 1a _ c ), a protein located in another insulin-insensitive cell. (For review see ref.
7.) In contrast, low intracellular glucose levels are present in insulin sensitive tissues like muscle cells and adipocytes. As expected, examination of skeletal and heart muscle from thirteen normal and two diabetic individuals yielded NEBG levels below detection limit, i.e., 0.06 nmol glucose/mg wet tissue or 2.3 nmol glucose//i,mol phenylalanine. Further, NEBG was found in skin, hair, bone, and fingernails (data not shown). The question remains whether modification of proteins by NEBG may be considered of importance for the development of diabetic late complications. We have therefore attempted to establish if there is an interrelationship between the occurrence of late complications and the respective levels of NEBG of the tissues. Late complications were evaluated from clinical and pathologic-anatomical diagnoses and arbitrarily graduated as slight = 0, medium = 1, severe = 2, and very severe = 3. Macroangiopathy was assessed from clinical accounts of coronary heart disease, circulatory disturbances, arterial occlusion, gangrene, and amputation as well as from postmortem examination of atherosclerotic lesions. Classification of retinopathy conformed with ophthalmologist's diagnosis corresponding to Ballantyne's criteria. Neuropathy was evaluated depending on the degree of clinical manifestations, such as paresthesia of extremities, muscular pain, weakness, and reflex anomalies. As clinical protocols provided no unequivocal information on diabetic nephropathy this was judged from glomerular changes observed on histologic examination. These fell only into three categories, i.e., 0, 1, and 2. It should be noted that patients for whom no clear clinical or pathologic data existed were not included in the whole evaluation. An arbitrary index of late complications was finally calculated by summing up the respective scores allotted to macroangiopathy, microangiopathy, and neuropathy. This index is plotted on the ordinate in Figure 4 against the values of NEBG of aortic tissue. In the diabetics, there appears a tendency of an increase of the index of complications along with an increase in tissue glucosylation. The index of complications in the nondiabetic group in Figure 4 is accounted for by the atherosclerotic lesions usually met at autopsy. Clearly, the procedure for estimating the index of late complications appears not that accurate as to warrant calculation of a coefficient of correlation from the data in Figure 4 . Nevertheless, the results may be interpreted as to support the possibility that NEBG may be related with the sequelae of diabetes. No correlation was found when NEBG of aorta or tendon was compared with duration of diabetes (4-30 yr), or with therapy (oral antihyperglycemic agents versus insulin therapy).
DISCUSSION
There are only few data in the literature concerning NEG of human tissues. An increase of NEBG in skin collagen 8 ' 9 and glomerular basement membrane 10 from diabetics has been reported. Kohn and Schnider studying human diaphragmatic tendon found an increase of NEBG with age such that the values of older diabetics fell within the range of nondiabetics. 11 This was not confirmed by us. Thus, tendon or aorta from nondiabetics showed only a very slight and not significant augmentation of NEBG with age covering a life span from 2 mo up to 89 yr (data not shown). The choice of a less specific method for quantitation of NEBG by the above authors may explain this discrepancy. From present available evidence, it appears quite clear that collagen is a major target for NEBG but one can only speculate on the possible implications of this alteration in diabetes. Blocking of specific lysine-and hydroxylysine amino groups by glucose may lead to abnormal cross-linking and ensuing structural and functional changes of the collagens. The same may apply for elastin. If so, this could provide a molecular basis for some of the known diabetes-related lesions such as defective glomerular filtration, tendon contractures, and limited joint mobility, 12 dermal thickness and waxy skin, 12 abnormal lung elasticity and decreased total lung capacity, 13 and others. Our finding of an increase of NEBG in lung connective tissue from diabetics may bear on the latter aspect. An increase of NEBG as reported in the aorta of diabetic rats 14 is confirmed in this study to occur also in human aorta and coronary artery. It is possible that in the human blood vessels, as in rat aorta, it is also collagen that is glucosylated yet this has not been examined. The relevance, if any, of these changes for the predisposition to atherosclerosis in diabetes is an important goal for further investigation. Increased NEBG of nerve tissue has so far only been observed in diabetic rats. 15 Our data show that this holds true also for peripheral nerve tissue from human diabetics. Nothing is known at present on adverse effects of NEG on nerve cell physiology that might be related to diabetic neuropathy.
In conclusion, modification of proteins by NEG appears of potential interest with regard to the development of diabetic macroangiopathy, microangiopathy, and neuropathy. It seems now well established that hyperglycemia and accumulation of glucose in many insulin-independent tissues result in a surplus of covalent glucose attachment to protein amino groups. There is, however, still little known about whether this modification may alter the properties of the proteins in such a way that affects the integrity of the cells. Some supporting evidence may be derived from our data in Figure 4 , suggesting that the accumulation on NEBG in various tissues may be related to the extent and severity of late complications the patients had suffered from.
